{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["cancer survivorship", "chemotherapy-induced side effects", "neuropathic pain", "ozone therapy", "pelvic pain", "radiation-induced toxicity"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32379556", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "21"}, "DateRevised": {"Year": "2021", "Month": "06", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "05", "Day": "05"}], "ELocationID": ["10.1089/jpm.2019.0597"], "Journal": {"ISSN": "1557-7740", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jan"}}, "Title": "Journal of palliative medicine", "ISOAbbreviation": "J Palliat Med"}, "ArticleTitle": "Ozone Therapy in Refractory Pelvic Pain Syndromes Secondary to Cancer Treatment: A New Approach Warranting Exploration.", "Pagination": {"StartPage": "97", "EndPage": "102", "MedlinePgn": "97-102"}, "Abstract": {"AbstractText": ["<b><i>Background:</i></b> Chronic pain secondary to treatment in cancer survivors without tumor evidence is not unusual. Its management often requires specific approaches that are different from those applied for cancer patients with advanced disease and short life expectancy. Some studies have described clinical benefit with ozone therapy (O<sub>3</sub>T) in the management of pain and side effects secondary to cancer treatment. <b><i>Objective:</i></b> We present our preliminary experience with O<sub>3</sub>T in the management of refractory pelvic pain syndromes secondary to cancer treatment. <b><i>Design:</i></b> Case series. <b><i>Subjects and Methods:</i></b> Six cancer patients (without tumor evidence) who had been treated previously with radiotherapy, chemotherapy, or endoscopic procedures and were suffering persistent or severe pelvic pain (median 14 months) received O<sub>3</sub>T using ozone-oxygen gas mixture insufflation as a complementary therapy in addition to their scheduled conventional treatment. <b><i>Results:</i></b> All cases, except one, showed clinically relevant pain improvement. Visual analog scale score with the standard treatment was 7.8\u2009\u00b1\u20092.1 before O<sub>3</sub>T, 4.3\u2009\u00b1\u20093.4 (<i>p</i>\u2009=\u20090.049) after one month, 3.3\u2009\u00b1\u20093.7 (<i>p</i>\u2009=\u20090.024) after two months, and 2.8\u2009\u00b1\u20093.8 (<i>p</i>\u2009=\u20090.020) after three months of O<sub>3</sub>T. The median value of \"pain symptom\" according to the U.S. National Cancer Institute Common Terminology Criteria for Adverse Events v. 5.0 showed a decrease from 3 (range: 2-3) to 1 (range: 0-3) (<i>p</i>\u2009=\u20090.046). <b><i>Conclusions:</i></b> Following unsuccessful conventional treatments, O<sub>3</sub>T provided significant benefit in our patients with refractory pelvic pain secondary to cancer treatment. These results merit further evaluation in blinded, randomized clinical trials."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Chronic Pain Unit, and Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Radiation Oncology, Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "BioPharm Group, Instituto Universitario de Investigaciones Biom\u00e9dicas y Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Grupo de Investigaci\u00f3n Cl\u00ednica en Oncolog\u00eda Radioter\u00e1pica (GICOR), Madrid, Spain."}], "LastName": "Clavo", "ForeName": "Bernardino", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chronic Pain Unit, and Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}], "LastName": "Navarro", "ForeName": "Minerva", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Radiation Oncology, Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}], "LastName": "Federico", "ForeName": "Mario", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnologies, University of Siena, Siena, Italy."}], "LastName": "Borrelli", "ForeName": "Emma", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chronic Pain Unit, and Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}], "LastName": "Jorge", "ForeName": "Ignacio J", "Initials": "IJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Radiation Oncology, Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}], "LastName": "Ribeiro", "ForeName": "Ivone", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Radiation Oncology, Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}], "LastName": "Rodr\u00edguez-Melcon", "ForeName": "Juan I", "Initials": "JI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chronic Pain Unit, and Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}], "LastName": "Caram\u00e9s", "ForeName": "Miguel A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "BioPharm Group, Instituto Universitario de Investigaciones Biom\u00e9dicas y Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Section of Thoracic Surgery, Department of Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Surgery, College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia."}], "LastName": "Santana-Rodr\u00edguez", "ForeName": "Norberto", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Dr. Negr\u00edn University Hospital, Las Palmas de Gran Canaria, Spain."}], "LastName": "Rodr\u00edguez-Esparrag\u00f3n", "ForeName": "Francisco", "Initials": "F"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Palliat Med", "NlmUniqueID": "9808462", "ISSNLinking": "1557-7740"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Chronic Pain"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Neoplasms"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug therapy", "etiology"], "DescriptorName": "Pelvic Pain"}, {"QualifierName": [], "DescriptorName": "Syndrome"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "5", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "8", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32379556", "10.1089/jpm.2019.0597"]}}], "PubmedBookArticle": []}